X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (354) 354
Publication (44) 44
Newsletter (28) 28
Book / eBook (4) 4
Book Chapter (4) 4
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (324) 324
index medicus (183) 183
cancer (115) 115
male (104) 104
animals (102) 102
female (94) 94
oncology (89) 89
lymphomas (87) 87
middle aged (75) 75
hematology (69) 69
lymphoma (65) 65
adult (64) 64
aged (62) 62
expression (58) 58
non-hodgkin's lymphomas (58) 58
apoptosis (56) 56
t-cell lymphoma (55) 55
cell line, tumor (54) 54
pathology (54) 54
research (54) 54
skin neoplasms - enzymology (53) 53
t cells (53) 53
skin neoplasms - pathology (49) 49
immunohistochemistry (48) 48
neoplasms - enzymology (41) 41
antineoplastic agents - therapeutic use (40) 40
proteins (39) 39
gene expression (38) 38
histone deacetylases - metabolism (38) 38
care and treatment (37) 37
histone deacetylase inhibitors (37) 37
lymphoma - enzymology (37) 37
leukemia (36) 36
neoplasms - drug therapy (36) 36
pharmacology & pharmacy (35) 35
genetic aspects (34) 34
prognosis (34) 34
mice (33) 33
tumors (33) 33
aged, 80 and over (32) 32
antineoplastic agents - pharmacology (32) 32
cell biology (32) 32
enzymes (32) 32
dermatology (31) 31
activation (30) 30
lymphoma, t-cell, cutaneous - enzymology (30) 30
medicine (29) 29
analysis (28) 28
health aspects (28) 28
histone deacetylase inhibitors - pharmacology (28) 28
lymphoma, large-cell, anaplastic - enzymology (28) 28
lymphoma, t-cell - enzymology (28) 28
non-hodgkins-lymphoma (28) 28
research article (28) 28
apoptosis - drug effects (27) 27
hemic and lymphatic diseases (26) 26
kinases (26) 26
suberoylanilide hydroxamic acid (26) 26
gene expression regulation, neoplastic (24) 24
lymphoma, t-cell, cutaneous - pathology (24) 24
medicine, research & experimental (24) 24
protein-tyrosine kinases - metabolism (24) 24
article (23) 23
mycosis-fungoides (23) 23
chronic lymphocytic-leukemia (22) 22
t-lymphocytes - enzymology (22) 22
cell cycle (21) 21
immunology (21) 21
adolescent (20) 20
child (20) 20
histone deacetylase inhibitor (20) 20
histone deacetylase inhibitors - therapeutic use (20) 20
multidisciplinary sciences (20) 20
acetylation (19) 19
biomarkers, tumor - metabolism (19) 19
genes (19) 19
phosphorylation (19) 19
receptor protein-tyrosine kinases (19) 19
biochemistry & molecular biology (18) 18
cell proliferation (18) 18
lymphocytes (18) 18
lymphoma, non-hodgkin - enzymology (18) 18
multiple-myeloma (18) 18
physiological aspects (18) 18
clinical trials as topic (17) 17
diagnosis (17) 17
disease (17) 17
dose-response relationship, drug (17) 17
enzyme inhibitors - pharmacology (17) 17
epigenetics (17) 17
gene-expression (17) 17
lymphoma, large b-cell, diffuse - enzymology (17) 17
survival (17) 17
tumor cells, cultured (17) 17
alk (16) 16
biochemistry (16) 16
breast-cancer (16) 16
cell proliferation - drug effects (16) 16
drug therapy (16) 16
hematology, oncology and palliative medicine (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BLOOD, ISSN 0006-4971, 02/2018, Volume 131, Issue 8, pp. 888 - 898
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 2017, Volume 41, Issue 12, pp. 1581 - 1592
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 07/2010, Volume 10, Issue 7, pp. 997 - 1008
Romidepsin is a histone deacetylase inhibitor (HDI), approved by the US FDA for the treatment of cutaneous T-cell lymphoma (CTCL). Although various mechanisms... 
peripheral T-cell lymphoma | romidepsin | cutaneous T-cell lymphoma | histone deacetylase inhibitor | SUBEROYLANILIDE HYDROXAMIC ACID | CHROMOBACTERIUM-VIOLACEUM NO-968 | FK228 DEPSIPEPTIDE | MYCOSIS-FUNGOIDES | DEPSIPEPTIDE FR901228 | CHAPERONE FUNCTION | PHASE-II TRIAL | GAMMA-H2AX FOCI | COLORECTAL-CANCER PATIENTS | ONCOLOGY | Humans | Neoplasm Proteins - physiology | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Depsipeptides - pharmacology | Fatigue - chemically induced | Lymphoma, T-Cell, Cutaneous - drug therapy | Infection - etiology | Antineoplastic Agents - adverse effects | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Molecular Structure | Heart Diseases - chemically induced | Depsipeptides - adverse effects | Gene Targeting | Bone Marrow Diseases - chemically induced | Neoplasms - enzymology | Neoplasms - drug therapy | Lymphoma, T-Cell, Cutaneous - pathology | Lymphoma, T-Cell, Cutaneous - enzymology | Histone Deacetylase Inhibitors - pharmacology | Histone Deacetylase Inhibitors - therapeutic use | Histone Deacetylases - physiology | Gastrointestinal Diseases - chemically induced | Histone Deacetylase Inhibitors - adverse effects | Clinical Trials, Phase II as Topic | Practice Guidelines as Topic | Lymphomas | Genetic aspects | Research | Diagnosis | Romidepsin | Gene expression | Drug therapy | Health aspects | Apoptosis
Journal Article
Blood, ISSN 0006-4971, 03/2014, Volume 123, Issue 12, pp. 1850 - 1859
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 06/2008, Volume 22, Issue 6, pp. 1139 - 1143
Peripheral T-cell lymphomas (PTCLs) are fatal in the majority of patients and novel treatments, such as protein tyrosine kinase (PTK) inhibition, are needed.... 
TARGET | ACTIVATION | Syk | ONCOLOGY | tyrosine kinase | TISSUE | MARKERS | peripheral T-cell lymphoma | FOLLICULAR LYMPHOMA | HEMATOLOGY | phosphorylation | EXPRESSION | Translocation, Genetic | Phosphorylation | Lymphoma, Extranodal NK-T-Cell - enzymology | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Child, Preschool | Male | Intracellular Signaling Peptides and Proteins - metabolism | Lymphoma, Large-Cell, Anaplastic - enzymology | Lymphoma, T-Cell, Cutaneous - genetics | Immunoenzyme Techniques | Lymphoma, Extranodal NK-T-Cell - genetics | Chromosomes, Human, Pair 9 - genetics | Protein-Tyrosine Kinases - genetics | Flow Cytometry | Aged, 80 and over | Adult | Female | Child | Intracellular Signaling Peptides and Proteins - genetics | Syk Kinase | Chromosomes, Human, Pair 5 - genetics | Lymphoma, Large-Cell, Anaplastic - genetics | Lymphoma, T-Cell, Peripheral - genetics | Immunophenotyping | In Situ Hybridization, Fluorescence | Blotting, Western | Lymphoma, T-Cell, Peripheral - enzymology | Lymphoma, T-Cell, Cutaneous - pathology | Lymphoma, T-Cell, Cutaneous - enzymology | Tyrosine - metabolism | Lymphoma, Extranodal NK-T-Cell - pathology | Lymphoma, T-Cell, Peripheral - pathology | Adolescent | Aged | Lymphoma, Large-Cell, Anaplastic - pathology | Control | T cell lymphoma | Protein tyrosine kinase | Genetic aspects | Research | Diagnosis | Gene expression | Drug therapy
Journal Article
Journal of Dermatological Science, ISSN 0923-1811, 2011, Volume 64, Issue 3, pp. 185 - 190
Abstract Background Aberrant expression of microRNAs (miRNAs) has been implicated in oncogenesis of various tumors and primary cutaneous T cell lymphomas.... 
Dermatology | Prognostic factor | Primary cutaneous T cell lymphomas | Survival | Dicer, microRNA | ADENOCARCINOMA | MYCOSIS-FUNGOIDES | CLASSIFICATION | PROPOSAL | MICRORNAS | SEZARY-SYNDROME | DERMATOLOGY | TASK-FORCE | OF-CANCER EORTC | DROSHA | Immunohistochemistry | Lymphoma, Primary Cutaneous Anaplastic Large Cell - enzymology | Up-Regulation | Humans | Middle Aged | Lymphoma, T-Cell, Cutaneous - therapy | Male | DEAD-box RNA Helicases - analysis | Lymphoma, T-Cell, Cutaneous - genetics | Ribonuclease III - analysis | Mycosis Fungoides - enzymology | Austria | Lymphoma, T-Cell - enzymology | Skin Neoplasms - enzymology | Lymphomatoid Papulosis - enzymology | Time Factors | Skin Neoplasms - mortality | Sezary Syndrome - enzymology | Aged, 80 and over | Adult | Female | Retrospective Studies | Skin Neoplasms - pathology | Panniculitis - enzymology | Lymphoma, T-Cell, Cutaneous - mortality | Risk Assessment | Skin Neoplasms - therapy | Biomarkers, Tumor - analysis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Disease Progression | Lymphoma, T-Cell, Cutaneous - pathology | Disease-Free Survival | Lymphoma, T-Cell, Cutaneous - enzymology | Skin Neoplasms - genetics | Aged | Neoplasm Staging | Medical colleges | MicroRNA | Ribonuclease | Non-Hodgkin's lymphomas | T cells
Journal Article
Journal Article